Search
Growing up poor is about more than just the size of your bank account. Read the new CoLab Impact of Poverty Evidence Report.
A The Kids Research Institute Australia researcher focused on promoting more active childhoods to improve child health and wellbeing will be named amongst WA’s most outstanding young scientists at the upcoming 2020 Young Tall Poppy Science Awards.
The Kids Research Institute Australia is pleased to share in $490,000 in State Government funding designed to provide vital support to WA’s innovation sector in the wake of COVID-19.
Four The Kids Research Institute Australia-based biobanks which underpin a range of cancer, respiratory and early life research have received more than $450,000 in funding.
A The Kids Research Institute Australia PhD student has been awarded Western Australia’s only 2022 postgraduate scholarship by the National Health and Medical Research Council
A new The Kids Research Institute Australia-led report into the impact of state and national policy on children’s health has called for kids and families to have more say when it comes
The Kids Research Institute Australia has backed a series of transport priorities to keep children safer on the roads, boost physical activity levels, and save the economy billions of dollars.
WHO, as requested by its member states, launched the Expanded Programme on Immunization (EPI) in 1974 to make life-saving vaccines available to all globally. To mark the 50-year anniversary of EPI, we sought to quantify the public health impact of vaccination globally since the programme's inception.
Congratulations to four outstanding The Kids Research Institute Australia researchers who have received funding designed to support researchers who have narrowly missed out on highly competitive national funding.
Pneumococcal conjugate vaccine (PCV) prevents pneumococcal disease and pneumonia, but indirect effects are poorly understood in low-coverage, high-burden settings like Papua New Guinea (PNG). PNG introduced 13-valent PCV (PCV13) in 2014. We aimed to assess direct and indirect effectiveness of PCV13 against vaccine-type pneumococcal carriage among children with pneumonia or suspected meningitis in PNG